Scarica l'app Stockscreener
9.63
0.35%
-0.04
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Champions Oncology Inc Borsa (CSBR) Ultime notizie
Addressing Climate Change by Changing Our Food Systems - NTB Kommunikasjon
Champions Oncology integrates Cytek Aurora flow cytometers - Yahoo Finance
IXOPAY & Riskified Announce Partnership to Boost Fraud Prevention and Enhance Enterprise Payment Orchestration - Via Ritzau
Champions Oncology bolsters bioanalytical services By Investing.com - Investing.com Canada
Champions Oncology bolsters bioanalytical services - Investing.com India
Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership - AccessWire
Champions Oncology Boosts Bioanalytical Services with Cytek Aurora Tech and Key Executive Hire - StockTitan
Champions Oncology, Inc.'s (NASDAQ:CSBR) market cap up US$26m last week, benefiting both private equity firms who own 30% as well as insiders - Simply Wall St
Linacre Investments Limited Delivers Record-Breaking Returns for 2024 - Via Ritzau
Patient Derived Xenograft Model Market Future Business - openPR
CSBR stock hits 52-week high at $9.94 amid growth By Investing.com - Investing.com Australia
CSBR stock hits 52-week high at $9.94 amid growth - Investing.com
Ch Champions Oncology, Inc. Enhances Clinical Bioanalytical Services Portfolio with New Technology - Marketscreener.com
Learn to Evaluate (CSBR) using the Charts - Stock Traders Daily
Champions Oncology Reports Quarterly Revenue of $6.7 Million - AccessWire
CSBR stock touches 52-week high at $8.92 amid robust growth - Investing.com Nigeria
CSBR stock touches 52-week high at $8.92 amid robust growth By Investing.com - Investing.com South Africa
Champions Oncology: Right Point To Own In The Cycle Thanks To Operating Efficiencies - Seeking Alpha
The Bilingual Book Company Launches New, Innovative Bilingual Audiobook App - NTB Kommunikasjon
Beyond Work Unveils Next-Generation Memory-Augmented AI Agent (MATRIX) for Enterprise Document Intelligence - Via Ritzau
Private equity firms invested in Champions Oncology, Inc. (NASDAQ:CSBR) up 19% last week, insiders too were rewarded - Yahoo Finance
CSBR stock hits 52-week high at $7.15 amid robust growth - Investing.com Australia
Champions Oncology Second Quarter 2025 Earnings: EPS: US$0.054 (vs US$0.15 loss in 2Q 2024) - Simply Wall St
Champions Oncology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2024 - Marketscreener.com
Champions Oncology, Inc. (NASDAQ:CSBR) Q2 2025 Earnings Call Transcript - Insider Monkey
Champions Oncology Inc. (CSBR) reports earnings - Quartz
Loar Holdings Inc. Announces the Grant of Inducement Awards - Via Ritzau
Earnings call transcript: Champions Oncology Q2 2024 beats forecasts, stock surges - Investing.com
Champions Oncology Posts Strong Quarterly Revenue Growth - TipRanks
Champions Oncology earnings beat by $0.08, revenue topped estimates - Investing.com Canada
Stocks to Watch : Adobe, Champions Oncology, DBV Technologies - Marketscreener.com
Stocks to Watch: Adobe, Champions Oncology, DBV Technologies - MarketWatch
Champions Oncology Shares Rise on Higher 2Q Profit, Revenue - MarketWatch
Champions Oncology Q2 Earnings Surge: Revenue Soars 17% as Operational Efficiency Drives Profitability - StockTitan
Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million - AccessWire
Adobe, Macy's, Nordson, and more set to report earnings Wednesday By Investing.com - Investing.com Nigeria
3 US Dividend Stocks To Consider With Up To 4.6% Yield - Simply Wall St
Is Koppers Holdings (NYSE:KOP) Using Too Much Debt? - Simply Wall St
Sentiment Still Eluding Champions Oncology, Inc. (NASDAQ:CSBR) - Simply Wall St
Patient Derived Xenograft Model Market Is Booming Worldwide - openPR
Champions Oncology Sets Date for Q2 2024 Earnings Release & Conference Call - StockTitan
Polaris Renewable Energy Successfully Settles USD 175 Million Bond Issue - TT Nyhetsbyrån
[Latest] Patient Derived Xenograft (Pdx) Models Market : An Overview - openPR
Patient Derived Xenograft (PDX) Models Market Company - openPR
Polaris Renewable Energy Successfully Places USD 175 Million Bond Issue - NTB Kommunikasjon
Champions Oncology (NASDAQ:CSBR) shareholders have endured a 61% loss from investing in the stock three years ago - Yahoo Finance
Companies Like Champions Oncology (NASDAQ:CSBR) Can Afford To Invest In Growth - Simply Wall St
Shangri-La Mactan champions Breast Cancer Awareness with 'Pink Path to Hope' Fun Run and Wellness Forum - SunStar Philippines
CancerX Launches Expanded Accelerator Program for 2025, Partnering With KidsX to Transform Cancer Care Innovation - 01Net
Custom Assay Development Service Market Size, Share, Growth Forecast and Trends Analysis (2024-2032) - Economica
Opti Digital Breaks Down the Biggest AdTech Trends in 2025 - Via Ritzau
Patient Derived Xenograft Model Market Set for Explosive Growth - openPR
Champions Oncology announces stockholder meeting results - Investing.com India
0.62%
5.64%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):